[go: up one dir, main page]

MX2012007704A - Composiciones nutritivas y metodos para usar las mismas. - Google Patents

Composiciones nutritivas y metodos para usar las mismas.

Info

Publication number
MX2012007704A
MX2012007704A MX2012007704A MX2012007704A MX2012007704A MX 2012007704 A MX2012007704 A MX 2012007704A MX 2012007704 A MX2012007704 A MX 2012007704A MX 2012007704 A MX2012007704 A MX 2012007704A MX 2012007704 A MX2012007704 A MX 2012007704A
Authority
MX
Mexico
Prior art keywords
sub
subjects
malnutrition
compositions
compounds
Prior art date
Application number
MX2012007704A
Other languages
English (en)
Inventor
Eileen Moore
Original Assignee
Pentec Health Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=44226741&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2012007704(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pentec Health Inc filed Critical Pentec Health Inc
Publication of MX2012007704A publication Critical patent/MX2012007704A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/401—Proline; Derivatives thereof, e.g. captopril
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4172—Imidazole-alkanecarboxylic acids, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • External Artificial Organs (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

La invención proporciona composiciones de nutrición parenteral intradialítica (IDPN = intradialytic parenteral nutrition) con bajos carbohidratos para el tratamiento de desnutrición en sujetos en diálisis. En algunas modalidades, las composiciones IDPN son ventajosas para el tratamiento de la desnutrición en sujetos diabéticos o que sufren de otras patologías relacionadas a la administración de glucosa o sujetos que se benefician de estricta administración de fluidos.
MX2012007704A 2010-01-04 2010-07-30 Composiciones nutritivas y metodos para usar las mismas. MX2012007704A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US29213910P 2010-01-04 2010-01-04
US29280610P 2010-01-06 2010-01-06
PCT/US2010/043944 WO2011081679A1 (en) 2010-01-04 2010-07-30 Nutritive compositions and methods of using same

Publications (1)

Publication Number Publication Date
MX2012007704A true MX2012007704A (es) 2013-01-29

Family

ID=44226741

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2012007704A MX2012007704A (es) 2010-01-04 2010-07-30 Composiciones nutritivas y metodos para usar las mismas.
MX2012007775A MX2012007775A (es) 2010-01-04 2010-12-15 Composiciones nutritivas y metodos para utilizar las mismas.

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2012007775A MX2012007775A (es) 2010-01-04 2010-12-15 Composiciones nutritivas y metodos para utilizar las mismas.

Country Status (13)

Country Link
US (3) US8927505B2 (es)
EP (2) EP2521559A4 (es)
JP (3) JP5774603B2 (es)
KR (2) KR20120125487A (es)
CN (2) CN102883729A (es)
AU (2) AU2010337355A1 (es)
BR (2) BR112012016435A2 (es)
CA (2) CA2786375A1 (es)
GB (2) GB2489163A (es)
IL (1) IL220715A0 (es)
MX (2) MX2012007704A (es)
NZ (2) NZ601027A (es)
WO (2) WO2011081679A1 (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100137693A1 (en) * 2005-11-01 2010-06-03 Fresenius Medical Care Holdings, Inc. Methods and systems for patient care
WO2007053683A2 (en) * 2005-11-01 2007-05-10 Fresenius Medical Care Holdings, Inc. Digital data entry methods and devices
AU2009268742C1 (en) * 2008-07-07 2013-11-28 Pentec Health, Inc. Nutritive compositions and methods of using same
US8698741B1 (en) 2009-01-16 2014-04-15 Fresenius Medical Care Holdings, Inc. Methods and apparatus for medical device cursor control and touchpad-based navigation
US10799117B2 (en) * 2009-11-05 2020-10-13 Fresenius Medical Care Holdings, Inc. Patient treatment and monitoring systems and methods with cause inferencing
US9585810B2 (en) 2010-10-14 2017-03-07 Fresenius Medical Care Holdings, Inc. Systems and methods for delivery of peritoneal dialysis (PD) solutions with integrated inter-chamber diffuser
US10010563B2 (en) * 2012-11-27 2018-07-03 Terumo Kabushiki Kaisha Peritoneal dialysis fluid
JP7063468B2 (ja) 2015-09-21 2022-05-09 ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー がんに対する栄養処置
SE542106C2 (en) * 2016-08-26 2020-02-25 Atif M Dabdoub Dietary macro/micronutritional supplement for patients undergoing kidney dialysis
CA3084319A1 (en) * 2017-12-11 2019-06-20 Filtricine, Inc. Compositions, methods, kits and systems for cancer treatment and metabolic intervention therapy
AU2020316017A1 (en) * 2019-07-19 2022-02-17 Filtricine, Inc. Compositions, methods, kits and systems for cancer treatment and metabolic intervention therapy and other uses
US11278510B2 (en) 2019-09-05 2022-03-22 Baxter International Inc. Parenteral nutrition formulation with optimized amino acid and glucose content

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4489097A (en) 1976-07-28 1984-12-18 The Procter & Gamble Company Intravenous solutions with antimicrobial agent
JPS58500563A (ja) 1981-04-27 1983-04-14 バクスタ−、トラベノ−ル、ラボラトリ−ズ、インコ−ポレイテツド グルコ−ス、アミノ酸およびインシユリンを含む透析液
US4491589A (en) 1982-05-17 1985-01-01 The Trustees Of Columbia University In The City Of New York Amino acid solutions for parenteral nutrition and methods of formulation and use
US4604286A (en) * 1984-09-17 1986-08-05 Daigo Nutritive Chemicals, Ltd. Infusion solution for parenteral nutrition
JPS6178719A (ja) 1984-09-25 1986-04-22 Tanabe Seiyaku Co Ltd 総合輸液剤
JPH0667831B2 (ja) * 1986-01-13 1994-08-31 森永乳業株式会社 肝物質合成機能障害改善用のアミノ酸組成物
US5122515A (en) 1990-06-19 1992-06-16 Smith Ross C Nutrient composition containing dipeptides and method for administering the same
US5278149A (en) 1992-01-17 1994-01-11 New England Deaconess Hospital Corporation Method of preparing total parenteral nutrition solutions
US6380163B1 (en) 1992-12-22 2002-04-30 Baxter International Inc. Peritoneal dialysis solutions with polypeptides
US5571783A (en) 1993-03-09 1996-11-05 Clintec Nutrition Company Composition and method for treating patients with hepatic disease
JP2990686B2 (ja) 1994-11-17 1999-12-13 田辺製薬株式会社 水溶性ビタミンｂ類配合総合輸液
US6852690B1 (en) * 1995-08-22 2005-02-08 Amylin Pharmaceuticals, Inc. Method and composition for enhanced parenteral nutrition
US6077828A (en) 1996-04-25 2000-06-20 Abbott Laboratories Method for the prevention and treatment of cachexia and anorexia
SE9703775L (sv) 1997-10-16 1999-04-17 Pharmalink Baslaekemedel Ab Framställning av sterial lösningar som innehåller glukos
US6610206B1 (en) 1998-10-20 2003-08-26 Advanced Renal Technologies Buffered compositions for dialysis
US7670491B2 (en) 1998-10-20 2010-03-02 Advanced Renal Technologies Buffered compositions for dialysis
JP2002045420A (ja) 2000-08-01 2002-02-12 Terumo Corp 血液浄化装置、血液浄化方法および透析液パッケージ
RU2298428C2 (ru) 2001-02-07 2007-05-10 Нефрос, Инк. Способ и устройство для гемодиафильтровального приемно-выводного модуля
EP1279400A1 (en) 2001-07-25 2003-01-29 Target Hit sa Modifying the fatty acid composition of cell membranes of organs and tissues
US7445801B2 (en) 2002-06-07 2008-11-04 Baxter International Inc. Stable bicarbonate-based solution in a single container
US7323206B1 (en) 2003-03-04 2008-01-29 B. Braun Medical Inc. Reagents and methods for all-in-one total parenteral nutrition for neonates and infants
AU2004241840B2 (en) * 2003-05-22 2010-02-25 Otsuka Pharmaceutical Factory, Inc. Transfusion preparation for peripheral intravenous administration and method of stabilizing vitamin B1
US20050148647A1 (en) 2003-10-31 2005-07-07 Landry Donald W. Hemodialysis solutions and uses thereof
JP4622311B2 (ja) * 2004-05-21 2011-02-02 味の素株式会社 末梢静脈投与用輸液
JP2007056013A (ja) 2005-07-29 2007-03-08 Ajinomoto Co Inc 透析用補充液
BRPI0614521B8 (pt) 2005-08-02 2021-06-22 Baxter Healthcare Sa indicador de oxigênio para uso em produtos médicos
JP2007137836A (ja) 2005-11-21 2007-06-07 Ajinomoto Co Inc 末梢静脈栄養輸液
DE102006018293A1 (de) * 2006-04-20 2007-10-25 Fresenius Kabi Deutschland Gmbh Pädiatrische Aminosäurelösung zur parenteralen Ernäherung
JP5316918B2 (ja) 2006-04-24 2013-10-16 味の素株式会社 透析患者用輸液剤
CN101015501B (zh) * 2007-02-28 2012-03-07 华瑞制药有限公司 三腔袋包装的脂肪乳、氨基酸和葡萄糖注射液的组合物及其制备方法
WO2008146732A1 (ja) * 2007-05-25 2008-12-04 Ajinomoto Co., Inc. 末梢静脈投与用輸液
AU2009268742C1 (en) * 2008-07-07 2013-11-28 Pentec Health, Inc. Nutritive compositions and methods of using same
WO2010055963A1 (en) 2008-11-17 2010-05-20 Lee, Jin Tae Manufacturing method of acetate-free dialysate composition

Also Published As

Publication number Publication date
WO2011081679A1 (en) 2011-07-07
EP2521449A4 (en) 2013-04-24
EP2521449A1 (en) 2012-11-14
CA2786375A1 (en) 2011-07-07
NZ601043A (en) 2014-10-31
CN102883603A (zh) 2013-01-16
JP2015187112A (ja) 2015-10-29
MX2012007775A (es) 2013-02-21
AU2010337336A1 (en) 2012-07-26
GB2491279A (en) 2012-11-28
CA2786122A1 (en) 2011-07-11
JP2013516463A (ja) 2013-05-13
GB201211991D0 (en) 2012-08-22
US20120277170A1 (en) 2012-11-01
WO2011081660A1 (en) 2011-07-07
EP2521559A1 (en) 2012-11-14
JP2013516464A (ja) 2013-05-13
US20100317602A1 (en) 2010-12-16
GB201211987D0 (en) 2012-08-22
CN102883729A (zh) 2013-01-16
BR112012016435A2 (pt) 2019-09-24
BR112012016434A2 (pt) 2015-09-01
JP5774603B2 (ja) 2015-09-09
KR20120125487A (ko) 2012-11-15
IL220715A0 (en) 2012-08-30
US8927505B2 (en) 2015-01-06
EP2521559A4 (en) 2013-05-01
KR20120104417A (ko) 2012-09-20
NZ601027A (en) 2014-08-29
US20150080323A1 (en) 2015-03-19
GB2489163A (en) 2012-09-19
AU2010337355A1 (en) 2012-07-26

Similar Documents

Publication Publication Date Title
MX2012007704A (es) Composiciones nutritivas y metodos para usar las mismas.
BR112012002143B8 (pt) composto para redução dos níveis de hormônio da paratireóide, composição contendo o referido composto e uso do mesmo
WO2008067199A3 (en) Polycationic calcium modulator peptides for the treatment of hyperparathyroidism and hypercalcemic disorders
MX355063B (es) Calcimiméticos y métodos para su uso.
WO2010053548A3 (en) Pthr1 receptor compounds
MX2008013304A (es) Compuestos de peptido 1 tipo glucagon.
WO2015168618A3 (en) Compositions and methods for modulating growth hormone receptor expression
PH12014500558A1 (en) Composition for use in the promotion of healthy bone growth and/or in the prevention and/or treatment of bone disease
WO2007117366A3 (en) Systems and methods for stabilization of bone structures
PH12020552212A1 (en) Compositions and methods for the treatment of hemoglobinopathies and thalassemias
MX2013006073A (es) Dispositivos de recogida de sangre que contienen un agente estabilizador de sangre.
AU2017367699A8 (en) Fracture targeted bone regeneration through parathyroid hormone receptor stimulation
MX2010001987A (es) Un metodo para extender el intervalo de dosificacion de compuestos de vitamina d.
MX2010001584A (es) Tratamiento o prevencion de infeccion por rotavirus.
WO2011112893A3 (en) Compositions for ameliorating cell proliferative disorders and methods of making and using them
TR201907941T4 (tr) Paratiroid hormon seviyelerinin azaltılmasına yönelik terapötik ajanlar.
Avci Ibandronic acid
WO2012104838A8 (en) Use of hgh for the treatment of small for gestational age infants under two years of age
WO2008026078A3 (en) 19-nor-vitamin d analogs with 1,2,or 3,2 heterocyclic ring
TW200736207A (en) Methods of treating osteoporosis and secondary hyperparathyroidism using 20-methyl, gemini vitamin D3 compounds
Harahap CORRELATION BETWEEN MAMMOGRAPHIC BREAST DENSITY AND REPRODUCTIVE FACTORS OF WOMEN IN YOGYAKARTA
Duquenne Calcifediol/colecalciferol
Rachmiel et al. Reconstruction of the alveolar ridge by osteodistraction for implant placement
Akbar Worsening of abdominal pain: case report
WO2006033912A3 (en) Treatment of bone disorders with skeletal anabolic drugs

Legal Events

Date Code Title Description
FA Abandonment or withdrawal